Is an elevated pan-immune-inflammation value associated with increased mortality in patients with hypertension?
The pan-immune-inflammation value may serve as a prognostic biomarker for long-term mortality risk in patients with hypertension.
Elevated PIV was associated with increased all-cause mortality and cardiovascular mortality in hypertensive patients.
Wu et al. (Thu,) studied this question.